PTK2 is a potential biomarker and therapeutic target for EGFR- or TLRs-induced lung cancer progression via the regulation of the cross-talk between EGFR- and TLRs-mediated signals

• Main Authors: Ji Young Kim (Author), Ji Hye Shin (Author), Mi-Jeong Kim (Author), Bongkum Choi (Author), Yeeun Kang (Author), Jimin Choi (Author), Seo Hyun Kim (Author), Dohee Kwan (Author), Duk-Hwan Kim (Author), Eunyoung Chun (Author), Ki-Young Lee (Author)
• Format: Book
• Published: BMC, 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Protein tyrosine kinase 2 (PTK2), epidermal growth factor receptor (EGFR), and toll-like receptor (TLRs) are amplified in non-small cell lung cancer (NSCLC). However, the functional and clinical associations between them have not been elucidated yet in NSCLC. By using microarray data of non...